NIH-Funded Study Shows Sorafenib Improves Progression-Free Survival for Patients with Rare Sarcomas

  • Gary Schwartz

Press/Media

Period28 Mar 2018

Media coverage

1

Media coverage

  • TitleNIH-Funded Study Shows Sorafenib Improves Progression-Free Survival for Patients with Rare Sarcomas
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date28/03/18
    PersonsGary Schwartz